Healthcare Exoskeleton Market - Forecasts from 2019 to 2024

November 2019 | 98 pages | ID: HE5F81E78948EN
Knowledge Sourcing Intelligence LLP

Abstracts

The healthcare exoskeleton market is projected to grow at a CAGR of 36.03% to reach US$4,495.972 million by 2024, from US$709.742 million in 2018. The global market for exoskeleton is largely driven by recent advances in technology coupled with rising adoption of exoskeletons in the military and industrial sector. The growing demand for exoskeleton in rehabilitation, as well as increasing number of people suffering from spinal cord injuries, will boost the demand for exoskeletons. The continuous product innovation will augment the demand for exoskeletons in the coming years. In addition to this, the rising adoption of exoskeletons in developing countries will further add to their demand over the projected period.

The Healthcare exoskeleton Market – Forecasts from 2019 to 2024 is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by type, extremity, and geography.

The healthcare exoskeleton market has been segmented based on type, extremity, and geography. By type, the market has been segmented on the basis of powered exoskeleton and passive exoskeleton. By extremity, the market has been segmented as lower and upper extremity.

Regional analysis has been provided with detailed analysis and forecast for the period 2018 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa (MEA), and the Asia Pacific regions. The report also analyzes 13 countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.

Major players in healthcare exoskeleton market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in healthcare exoskeleton market.

Segmentation

The healthcare exoskeleton market has been segmented by type, extremity, and geography.

• By Type
• Powered Exoskeleton
• Passive Exoskeleton
• By Extremity
• Lower Extremity
• Upper Extremity
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Others
• Europe
• Germany
• France
• United Kingdom
• Italy
• Others
• Middle East and Africa
• Israel
• Others
• Asia Pacific
• China
• Japan
• South Korea
• India
• Others

'The report will be delivered in 3 working days.'

Contents

1. INTRODUCTION

1.1. Market Definition
1.2. Market Segmentation

2. RESEARCH METHODOLOGY

2.1. Research Data
2.2. Assumptions

3. EXECUTIVE SUMMARY

3.1. Research Highlights

4. MARKET DYNAMICS

4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
  4.3.1. Bargaining Power of Suppliers
  4.3.2. Bargaining Power of Buyers
  4.3.3. Threat of New Entrants
  4.3.4. Threat of Substitutes
  4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis

5. HEALTHCARE EXOSKELETON MARKET ANALYSIS, BY TYPE

5.1. Introduction
5.2. Powered Exoskeleton
5.3. Passive Exoskeleton

6. HEALTHCARE EXOSKELETON MARKET ANALYSIS, BY EXTREMITY

6.1. Introduction
6.2. Lower Extremity
6.3. Upper Extremity

7. HEALTHCARE EXOSKELETON MARKET ANALYSIS, BY GEOGRAPHY

7.1. Introduction
7.2. North America
  7.2.1. North America Healthcare exoskeleton Market, By Type, 2018 to 2024
  7.2.2. North America Healthcare exoskeleton Market, By Extremity, 2018 to 2024
  7.2.3. By Country
    7.2.3.1. United States
      7.2.3.1.1. By Type
      7.2.3.1.2. By Extremity
    7.2.3.2. Canada
      7.2.3.2.1. By Type
      7.2.3.2.2. By Extremity
    7.2.3.3. Mexico
      7.2.3.3.1. By Type
      7.2.3.3.2. By Extremity
7.3. South America
  7.3.1. South America Healthcare exoskeleton Market, By Type, 2018 to 2024
  7.3.2. South America Healthcare exoskeleton Market, By Extremity, 2018 to 2024
  7.3.3. By Country
    7.3.3.1. Brazil
      7.3.3.1.1. By Type
      7.3.3.1.2. By Extremity
    7.3.3.2. Others
7.4. Europe
  7.4.1. Europe Healthcare exoskeleton Market, By Type, 2018 to 2024
  7.4.2. Europe Healthcare exoskeleton Market, By Extremity, 2018 to 2024
  7.4.3. By Country
    7.4.3.1. Germany
      7.4.3.1.1. By Type
      7.4.3.1.2. By Extremity
    7.4.3.2. France
      7.4.3.2.1. By Type
      7.4.3.2.2. By Extremity
    7.4.3.3. United Kingdom
      7.4.3.3.1. By Type
      7.4.3.3.2. By Extremity
    7.4.3.4. Italy
      7.4.3.4.1. By Type
      7.4.3.4.2. By Extremity
    7.4.3.5. Others
7.5. Middle East and Africa
  7.5.1. Middle East and Africa Healthcare exoskeleton Market, By Type, 2018 to 2024
  7.5.2. Middle East and Africa Healthcare exoskeleton Market, By Extremity, 2018 to 2024
  7.5.3. By Country
    7.5.3.1. Israel
      7.5.3.1.1. By Type
      7.5.3.1.2. By Extremity
    7.5.3.2. Others
7.6. Asia Pacific
  7.6.1. Asia Pacific Healthcare exoskeleton Market, By Type, 2018 to 2024
  7.6.2. Asia Pacific Healthcare exoskeleton Market, By Extremity, 2018 to 2024
  7.6.3. By Country
    7.6.3.1. China
      7.6.3.1.1. By Type
      7.6.3.1.2. By Extremity
    7.6.3.2. Japan
      7.6.3.2.1. By Type
      7.6.3.2.2. By Extremity
    7.6.3.3. South Korea
      7.6.3.3.1. By Type
      7.6.3.3.2. By Extremity
    7.6.3.4. India
      7.6.3.4.1. By Type
      7.6.3.4.2. By Extremity
    7.6.3.5. Others

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix

9. COMPANY PROFILES

9.1. Rex Bionics Ltd.
9.2. ReWalk Robotics
9.3. Ekso Bionics
9.4. CYBERDYNE, INC.
9.5. MARSI BIONICS, S.L.
9.6. B-Temia Inc.
9.7. US Bionics, Inc.
9.8. Hocoma
9.9. Myomo Inc.
9.10. Honda Motor Co., Ltd.

10. APPENDIX